Additionally, although abnormally high levels of MT1-MMP overexpression may not reflect those seen in primary breast cancers, there is still mechanistic value in this approach, as utilized in this study to demonstrate the constancy of the TIMP-2 mediated activation of proMMP-2 by MT1-MMP. The gene discussed is TIMP2; the disease is breast cancer.